(Q47844161)

6 February 2018

title

Putative aggregation initiation sites in prion protein (English)

1 reference

6 February 2018

0 references

Jan Ziegler

1

1 reference

6 February 2018

Christine Viehrig

2

1 reference

6 February 2018

Stefan Geimer

3

1 reference

6 February 2018

Paul Rösch

4

1 reference

6 February 2018

Stephan Schwarzinger

5

1 reference

6 February 2018

language of work or name

English

0 references

publication date

10 March 2006

1 reference

6 February 2018

published in

FEBS Letters

1 reference

6 February 2018

volume

580

1 reference

6 February 2018

issue

8

1 reference

6 February 2018

page(s)

2033-2040

1 reference

6 February 2018

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

1 reference

NMR solution structure of the human prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

21 January 2018

Copper and prion disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

The biology of the cellular prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Cellular prion protein transduces neuroprotective signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Signal transduction through prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Evidence for assembly of prions with left-handed beta-helices into trimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Structural studies of the scrapie prion protein by electron crystallography

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Protein misfolding, evolution and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Designing conditions for in vitro formation of amyloid protofilaments and fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Sequence determinants of amyloid fibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Emerging ideas on the molecular basis of protein and peptide aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Molecular hinges in protein folding: the urea-denatured state of apomyoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Designing proteins from the inside out.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

The Octapeptide Repeats in Mammalian Prion Protein Constitute a pH-dependent Folding and Aggregation Site

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

CD and NMR studies of prion protein (PrP) helix 1. Novel implications for its role in the PrPC-->PrPSc conversion process

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

The aggregation kinetics of Alzheimer's beta-amyloid peptide is controlled by stochastic nucleation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Molecular basis of barriers for interspecies transmissibility of mammalian prions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

From conversion to aggregation: protofibril formation of the prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Synthetic mammalian prions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Locally disordered conformer of the hamster prion protein: a crucial intermediate to PrPSc?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Definable equilibrium states in the folding of human prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

The effect of disease-associated mutations on the folding pathway of human prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Predicted alpha-helical regions of the prion protein when synthesized as peptides form amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Aggregation of liposomes induced by the toxic peptides Alzheimer's Abetas, human amylin and prion (106-126): facilitation by membrane-bound GM1 ganglioside

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Glycine residues appear to be evolutionarily conserved for their ability to inhibit aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

A transmembrane form of the prion protein in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Polyproline II structure in a sequence of seven alanine residues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Neighbor effect on PPII conformation in alanine peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.03.002

10.1016/J.FEBSLET.2006.03.002

21 January 2018

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018